~~<i id='5EA8C9CC60'><strike id='5EA8C9CC60'><tt id='5EA8C9CC60'><pre id='5EA8C9CC60'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：Wikipedia 2025-09-29 08:07:10 Page View：185

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： AstraZeneca chief proposes a novel edit to the drug pricing bill
Next article： Moonlake's readout produced a cash windfall. Risks remain

comprehensive

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Why Novartis is changing the name of its research labs

FionaMarshall,presidentoftheNovartisresearchhubinCambridge,Mass.,speaksThursdayduringtheSTATFutureSu

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

How generative AI is inspiring dreams of a health data revolution

MollyFergusonforSTATTheworld’slargesttechnologycompaniesareracingtobuildgenerativeAIintoeverycornero